inflammation of the pancreas pancreatitis.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • Have 2 out of 3 revised Atlanta criteria for pancreatitis: - Abdominal pain consistent with acute pancreatitis - serum lipase >= 3x upper limit normal (> 159 U/l) - typical pancreatic abnormalities on imaging (ultrasound, CT or MRI) • First episode of acute pancreatitis or a prior pancreatitis more than 3 months ago. • Age >=18 years, both men and women. • Able and willing to provide written informed consent. • In possession of a working (smart)phone on which patient can be reached for the duration of participation (30 days).
Exclusion criteria
Exclusion criteria: • Chronic pancreatitis according to M-ANNHEIM criteria. • Signs of severe pancreatitis at the moment of admission to the GE ward: - serum CRP > 150 mg/l - more than one SIRS criteria: * temperature 38*C * heart rate > 90/min * respiratory rate >20/min * leucocytes 12x109/l • MEWS (Modified Early Warning Score) >=6 or in need of ICU admission • Living alone or in an institution (e.g. psychiatric ward or nursing home) • Known sensitivity to medical adhesives • Known pregnancy. • Have one or more of the following comorbidities: - Heart failure (NYHA class III or IV). - COPD (Gold III-IV). - Kidney disease (>G3b) and/or kidney replacement therapy. - Currently undergoing oncological treatment. - Use of immunosuppressants. - Dysregulated or poorly controlled insulin dependent diabetes. - Morbid obesity (BMI>35 kg/m2). - Implantable Cardioverter Defibrillator (ICD) or Pacemaker.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main endpoint of the study is the safety of early discharge with remote monitoring. Safety is defined by the incidence of unplanned hospital readmissions, the incidence of acute pancreatitis related complications and mortality, all within 30 days of hospital admission. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secundary parameters of the study are length of stay in the hospital, duration of home monitoring, the amount of extra contacts between the nurse and patient, the amount of laboratory of imaging tests, adjustments in pain medication, patient satisfaction and overall costs. | — |
Countries
Netherlands